Date and Type of Meeting

This is a Postal Ballot process, not a physical meeting. The notice was dispatched on October 23, 2026. The remote e-voting period is scheduled from Saturday, 24th October 2026 at 9:00 a.m. (IST) to Sunday, 22nd November 2026 at 5:00 p.m. (IST).

Summary of Proposed Resolution and Implications

The single resolution proposed is a Special Resolution for the re-appointment of Mr. Bhaskar Vemban Iyer (DIN: 00480341) as an Independent Director for a second term of five consecutive years, from 12th November 2026 to 11th November 2031.

Key Implications:

  • His appointment is not liable to retire by rotation.
  • His remuneration will consist of sitting fees for Board/Committee meetings and a commission within statutory limits.
  • The Board believes his continued association, with over four decades of pharmaceutical industry experience, will be beneficial for strategic planning, governance, and stakeholder value creation.

Voting Process and Methods

The voting will be conducted solely through remote e-voting (postal ballot).

  • The company has engaged Central Depository Services (India) Limited (CDSL) to provide the e-voting facility.
  • The cut-off date for determining shareholder eligibility is Friday, 16th October 2026.
  • Votes will be reckoned based on the paid-up value of shares held as of the cut-off date.
  • The notice was sent electronically to all members whose email IDs were registered with the company/RTA/Depositories as of the cut-off date.

Key Voting Outcomes and Scrutinizer

  • The final voting results and the scrutinizer's report will be declared on or before Tuesday, 24th November 2026.
  • The Board has appointed CS Ketan Ravindra Shirwadkar (FCS No. 13938; CP 15386), Proprietor of M/s. KRS & Co., Practicing Company Secretaries, as the Scrutinizer to conduct the voting process in a fair and transparent manner.
  • The scrutinizer will submit his report to the Chairman, and the results will be communicated to the stock exchanges (BSE and NSE), CDSL, and the RTA, and displayed on the company's website (www.themismedicare.com) and at its corporate and registered offices.

Compliance with Laws and Regulations

The notice and the entire process are explicitly stated to be in compliance with:

  • Section 110 of the Companies Act, 2013
  • Rule 22 of the Companies (Management and Administration) Rules, 2014
  • Secretarial Standard on General Meetings (SS-2)
  • MCA General Circulars Nos. 14/2020, 17/2020, 09/2024, and 03/2025
  • Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • The company's Articles of Association

Other Relevant Information

Company Details:

  • Corporate Office: 11/12 Udyog Nagar, S V Road, Goregaon (W), Mumbai – 400 104

Director Profile (Mr. Bhaskar Vemban Iyer):

  • Age: 70 years (DOB: 07-March-1956)
  • Current Remuneration (FY 2025-26): Rs. 8,20,000/- (sitting fees & commission)
  • Qualifications: B.Sc.; Master's Degree in Marketing Management (JBIMS)
  • Expertise: Pharmaceutical industry, strategic leadership, healthcare management.
  • Current Other Directorships (Listed): RPG Life Sciences Limited, Corona Remedies Limited, Gujarat Themis Biosyn Limited.
  • Attendance (FY 2025-26): Attended 5 out of 5 Board Meetings.
  • Shareholding in Themis Medicare: Nil